Clinical Trial Update: PK and Safety of Caffeine in Neonates With Hypoxic Ischemic Encephalopathy Receiving Therapeutic Hypothermia [Phase 1]

View source ↗

Summary

The clinical trial evaluating caffeine pharmacokinetics and safety in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy
• Kidney Injury

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: University of Arkansas | Conditions: Acute Kidney Injury, Hypoxic-Ischemic Encephalopathy | Phase 1 | Status: WITHDRAWN